Form 4: Broadwood Partners Increases Stake in STAAR Surgical Co (STAA)
SEC Form 4
Broadwood Partners, L.P., along with related entities and individuals, has increased its holdings in STAAR Surgical Co (STAA) through a series of open market purchases.
Summary
- Broadwood Partners, L.P. has reported changes in its beneficial ownership of STAAR Surgical Co (STAA) common stock.
- The transactions involved a series of purchases made between February 12, 2025, and February 14, 2025.
- The purchases were executed at varying prices, ranging from $13.50 to $15.99 per share.
- Following these transactions, Broadwood Partners directly owns 11,289,437 shares of STAAR Surgical Co.
- Neal C. Bradsher also directly owns 25,900 shares.
- Broadwood Capital, Inc., as the General Partner of Broadwood Partners, and Neal C. Bradsher, as President of Broadwood Capital, may be deemed to indirectly beneficially own the reported securities.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as a major shareholder is increasing their investment in the company, suggesting confidence in its future.
Positives
- The increased stake by Broadwood Partners could be interpreted as a sign of confidence in STAAR Surgical Co.'s future prospects.
Risks
- The document itself doesn't explicitly mention risks, but the increased ownership concentration could potentially lead to greater influence by Broadwood Partners in the company's decisions.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of insiders and major shareholders. This filing indicates increased investment by a significant shareholder, which can influence market perception of the company.
Comparison to Industry Standards
- Comparing Broadwood Partners' increased stake to similar investments in the ophthalmic device industry is difficult without knowing the specific investment strategies and portfolio allocations of other major shareholders in comparable companies such as Alcon, Johnson & Johnson Vision, or Carl Zeiss Meditec.
- Generally, a significant increase in ownership by a major shareholder is viewed positively, but the impact depends on the overall market sentiment and the company's performance.
Stakeholder Impact
- Shareholders may view the increased stake positively, potentially leading to a short-term increase in stock price.
- Employees may see it as a sign of stability and confidence in the company's leadership.
- Customers and suppliers may not be directly impacted by this transaction.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Earliest transaction date for reported stock purchases. |
| 02/12/2025 | Date of common stock purchase at $13.9853. |
| 02/12/2025 | Date of common stock purchase at $14.899. |
| 02/12/2025 | Date of common stock purchase at $15.7651. |
| 02/13/2025 | Date of common stock purchase at $15.8352. |
| 02/14/2025 | Date of common stock purchase at $15.4932. |
| 02/14/2025 | Date of report submission. |
Keywords
STAAR Surgical, Broadwood Partners, Beneficial Ownership, Stock Purchase, Form 4, STAA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.